[1] |
SONG J, CHEN LZ, ZHENG YY, et al. Correlation between β-fibrinogen gene-249 C / T polymorphism and coronary heart disease in Inner Mongolia[J]. J Baotou Med Coll, 2016, 32(8): 7-9. https://www.cnki.com.cn/Article/CJFDTOTAL-BTYX201608004.htm
宋剑, 陈丽珠, 郑玉云, 等. 内蒙古地区人纤维蛋白原β-249 C/T基因多态性与冠心病的相关性[J]. 包头医学院学报, 2016, 32(8): 7-9. https://www.cnki.com.cn/Article/CJFDTOTAL-BTYX201608004.htm
|
[2] |
LI JT, ZHAO HM, CHEN XH. Correlation between β-fibrinogen gene-455G/A polymorphism and plasma fibrinogen level and lacunar infraction[J]. Int J Cerebrovasc, 2019, 27(12): 902-908. DOI: 10.3760/cma.j.issn.1673-4165.2019.12.005.
李军廷, 赵鸿梅, 陈晓虹. β-纤维蛋白原基因-455G/A多态性与血浆纤维蛋白原水平及腔隙性脑梗死的相关性[J]. 国际脑血管病杂志, 2019, 27(12): 902-908. DOI: 10.3760/cma.j.issn.1673-4165.2019.12.005.
|
[3] |
QIN YL. The study of the relationships between the coagulo-fibrinolytic changes and the roles of fibrin(ogen) in cholesterol gallstone formation[D]. Nanjing: Southeast University, 2000.
秦永林. 纤维蛋白(原)和凝血、纤溶系统在胆囊胆固醇结石形成中的作用[D]. 南京: 东南大学, 2000.
|
[4] |
ZHU SZ. Therapeutic effect and related factors of human fibrinogen on traumat-ic traumatic coagulopathy[J]. Chin J Clin Pharmacol Ther, 2019, 24(6): 693-698. DOI: 10.12092/j.issn.1009-2501.2019.06.015.
朱悚之. 人纤维蛋白原对急诊外伤致创伤性凝血病疗效及相关因素分析[J]. 中国临床药理学与治疗学, 2019, 24(6): 693-698. DOI: 10.12092/j.issn.1009-2501.2019.06.015.
|
[5] |
FULLER GM, ZHANG Z. Transcriptional control mechanism of fibrinogen gene expression[J]. Ann N Y Acad Sci, 2001, 936: 469-479. DOI: 10.1111/j.1749-6632.2001.tb03534.x.
|
[6] |
LIU CH, GE YL, LI LR, et al. Polymorphism of fibrinogen Bβ-249C / T gene in smokers with COPD[J]. J Bengbu Med Coll, 2020, 45(2): 201-204. DOI: 10. 13898/ j. cnki. issn. 1000-2200. 2020. 02. 017.
刘聪辉, 戈艳蕾, 李丽蕊, 等. 慢性阻塞性肺疾病吸烟病人纤维蛋白原Bβ-249 C/T基因多态性[J]. 蚌埠医学院学报, 2020, 45(2): 201-204. DOI: 10. 13898/ j. cnki. issn. 1000-2200. 2020. 02. 017.
|
[7] |
DUAN JL, ZHANG XM, MENG PF, et al. Relationship between plasma fibrinogen gene polymorphism, obesity and ischemic cerebral stroke[J]. Chin J Integr Med Cardio/Cerebrovasc Dis, 2020, 18(13): 2168-2171. DOI: 10.12102/ji.ssn.1672-1349.2020.13.040.
段家乐, 张晓敏, 孟鹏飞, 等. 血浆纤维蛋白原基因多态性、肥胖与缺血性脑卒中的关系探讨[J]. 中西医结合心脑血管病杂志, 2020, 18(13): 2168-2171. DOI: 10.12102/ji.ssn.1672-1349.2020.13.040.
|
[8] |
ONG KL, TSO AW, CHERNY SS, et al. A genetic variant in the gene encoding fibrinogen beta chain predicted development of hypertension in Chinese men[J]. Thromb Haemost, 2010, 103(4): 728-735. DOI: 10.1160/TH09-10-0692.
|
[9] |
THEODORAKI EV, NIKOPENSIUS T, SUHORUTSENKO J, et al. Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study[J]. BMC Med Genet, 2010, 11: 28. DOI: 10.1186/1471-2350-11-28.
|
[10] |
INGEBRIGTSEN TS, MAROTT JL, RODE L, et al. Fibrinogen and α1-antitrypsin in COPD exacerbations[J]. Thorax, 2015, 70(11): 1014-1021. DOI: 10.1136/thoraxjnl-2015-207561.
|
[11] |
STINTON LM, MYERS RP, SHAFFER EA. Epidemiology of gallstones[J]. Gastroenterol Clin North Am, 2010, 39(2): 157-169, vii. DOI: 10.1016/j.gtc.2010.02.003.
|
[12] |
MIAO YG, XUE DB, ZHANG WH. Progress of research on the causes and treatment of Cholesterol Gallstones[J]. J Hepatopancreatobiliary Surg, 2016, 28(2): 155-157, 177. DOI: 10.11952/j.issn.1007-1954.2016.02.023.
苗彦国, 薛东波, 张伟辉. 胆囊胆固醇结石成因及其治疗研究进展[J]. 肝胆胰外科杂志, 2016, 28(2): 155-157, 177. DOI: 10.11952/j.issn.1007-1954.2016.02.023.
|
[13] |
LI WD. Epidemiological analysis of gallstone in Xinjiang[J]. Contemp Med Forum, 2014, 21: 187-188. https://www.cnki.com.cn/Article/CJFDTOTAL-QYWA201421157.htm
李卫东. 对新疆地区胆囊结石的流行病学分析[J]. 当代医药论丛, 2014, 21: 187-188. https://www.cnki.com.cn/Article/CJFDTOTAL-QYWA201421157.htm
|
[14] |
BODMER M, BRAUCHLI YB, KRÄHENBÜHL S, et al. Statin use and risk of gallstone disease followed by cholecystectomy[J]. JAMA, 2009, 302(18): 2001-2007. DOI: 10.1001/jama.2009.1601.
|
[15] |
ZHUANG JH, DILIMULATI, ZHOU GM, et al. Clinical analysis of 872 cases of cholelithiasis in Xinjiang[J]. J Hepatopancreatobiliary Surg, 2006, 18(1): 47-48. DOI: 10.11952/j.issn.1007-1954.2006.01.018.
庄建华, 地里木拉提, 周贵明, 等. 新疆维吾尔族聚居区居民胆结石872例临床分析[J]. 肝胆胰外科杂志, 2006, 18(1): 47-48. DOI: 10.11952/j.issn.1007-1954.2006.01.018.
|
[16] |
CANSECO-AVILA LM, LOPEZ-ROBLERO A, SERRANO-GUZMAN E, et al. Polymorphisms-455G/A and-148C/T and fibrinogen plasmatic level as risk markers of coronary disease and major adverse cardiovascular events[J]. Dis Markers, 2019, 2019: 5769514. DOI: 10.1155/2019/5769514.
|
[17] |
CRONJÉ HT, NIENABER-ROUSSEAU C, ZANDBERG L, et al. Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: Independent and IL-6-interactive associations[J]. PLoS One, 2017, 12(11): e0187712. DOI: 10.1371/journal.pone.0187712.
|